Medication and pregnancy counseling, an incomfortable role for the retail pharmacists;Un rôle difficile pour le pharmacien d'officine, le conseil en matière de médicament et grossesse

Annales Pharmaceutiques Francaises

Volumn 62, Issue 4, 2004, Pages 253-259

  Pellerin, P ^a   Elefant, E ^b  

^a Hôpital Trousseau ^*  (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Counseling; Drugs; Pharmacist; Pregnancy; Risk

Indexed keywords

TERATOGENIC AGENT;

ARTICLE; ATTITUDE; DRUG INFORMATION; DRUG USE; DRUG WITHDRAWAL; FEMALE; FRANCE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HUMAN; INFORMATION CENTER; INFORMATION SERVICE; MEDICAL INFORMATION; PATIENT CARE; PATIENT COUNSELING; PHARMACIST; PHARMACY; PREGNANCY; QUESTIONNAIRE; RESPONSIBILITY; RISK FACTOR; TERATOGENICITY;

EID: 3843142679     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4509(04)94310-6     Document Type: Article

References (12)

1. Lenz W. A short history of thalidomide embryopathy. Teratology 1988; 38: 203-19.
2. Mise au point sur le diéthylstilbestrol (DES) (Distilbè ne*, Stilboestrol-Borne*) et le risque de complications génitales et obstétricales. Communiqué du directeur général de l'Afssaps du 30/11/2002. http//:agmed.sante.gouv.fr
3. Koren G, Pastuzak A. Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester. Teratology 1990; 41: 657-61.
4. Jasper JD, Goel R, Einarson A, Gallo M, Koren G. Effect of framing on teratogenic risk perception in pregnant women. The Lancet 2001; 358: 1237-8.
5. Elefant E, Bavoux F, Vauzelle-Gardier C, Assari-Merabtene F. Grossesse, médicaments, vaccins et radiations in Traité d'Obstétrique. Paris: Médecines-Sciences Flammarion: 2003; 699-705.
6. Parrot J. De la prescrition au patient: l'apport du pharmacien ou l'opinion pharmaceutique. Bull Acad Natle Méd 1998; 7: 53-6.
7. Rubrique Grossesse et Allaitement. Libellé proposé par le groupe de travail «Reproduction, Grossesse et Allaitement». Informations de l'AFSSAPS. Dictionnaire Vidal. Paris: 2003; V.
8. Scialli A. Identifying teratogens: the tyranny of lists. Reprod Toxicol 1997; 11: 555-9.
9. Doering PL, Boothby LA, Cheok M. Review of pregnancy labeling for prescription drugs: is the current system adequate to inform risks? Am J Obstet Gynecol 2002; 187: 333-9.
10. Lo WY, Friedman JM. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol 2002; 100: 465-73.
11. Elefant E, Boyer M, Boyer P, Galliot B, Roux C. Teratogenic agent information centre: fifteen years of counseling and pregnancy follow-up. Teratology 1992; 46: 35-44
12. Clementi M, Di Gianantonio E, Ornoy A. Teratology Information Services in Europe and their contribution to the prevention of congenital anomalies. Community Genet 2002; 5: 8-12.